{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:33:59Z","timestamp":1785418439471,"version":"3.56.0"},"reference-count":19,"publisher":"SAABRON PRESS","issue":"4","license":[{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.46989\/001c.124551","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T22:05:31Z","timestamp":1729289131000},"source":"Crossref","is-referenced-by-count":3,"title":["Pulmonary GvHD: is it time to change the NIH diagnostic criteria?"],"prefix":"10.46989","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4703-6280","authenticated-orcid":false,"given":"Martina","family":"Canichella","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03h1gw307","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Eugenio Hospital","department":["Hematology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poalo","family":"de Fabritiis","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03h1gw307","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Eugenio Hospital","department":["Hematology"]},{"id":[{"id":"https:\/\/ror.org\/03z475876","id-type":"ROR","asserted-by":"publisher"}],"name":"Policlinico Tor Vergata"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"26435","published-online":{"date-parts":[[2024,10,19]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/S2352-3026(23)00342-3","article-title":"Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation","volume":"11","author":"O. Penack","year":"2024","journal-title":"Lancet Haematol"},{"issue":"22","key":"ref2","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1182\/blood.2021012021","article-title":"Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the Rockstar Study","volume":"138","author":"C. Cutler","year":"2021","journal-title":"Blood"},{"issue":"10","key":"ref3","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1200\/JCO.22.00958","article-title":"Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I\/II Study","volume":"41","author":"C. L. Kitko","year":"2023","journal-title":"J Clin Oncol"},{"issue":"3","key":"ref4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1152\/jappl.1969.27.3.328","article-title":"Physiological effects of experimental airway obstruction with beads","volume":"27","author":"R. Brown","year":"1969","journal-title":"J Appl Physiol"},{"issue":"7","key":"ref5","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jtct.2021.03.033","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report","volume":"27","author":"C. L. Kitko","year":"2021","journal-title":"Transplant Cell Ther."},{"issue":"6","key":"ref6","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.bbmt.2015.02.006","article-title":"Predictive value of bronchiolitis obliterans syndrome stage 0p in chronic graft-versus-host disease of the lung","volume":"21","author":"S. Abedin","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"169","key":"ref7","doi-asserted-by":"publisher","first-page":"220251","DOI":"10.1183\/16000617.0251-2022","article-title":"Multiple breath washout and oscillometry after allogenic HSCT: a scoping review","volume":"32","author":"N. Sonneveld","year":"2023","journal-title":"Eur Respir Rev"},{"issue":"5","key":"ref8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/sj.bmt.1703142","article-title":"Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation","volume":"28","author":"B. Afessa","year":"2001","journal-title":"Bone Marrow Transplantation"},{"issue":"14","key":"ref9","doi-asserted-by":"publisher","first-page":"4196","DOI":"10.1182\/bloodadvances","article-title":"The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host disease","volume":"6","author":"Y. Pang","year":"2022","journal-title":"Blood Adv"},{"issue":"7","key":"ref10","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1172\/JCI90593","article-title":"Cytokine mediators of chronic graft-versus-host disease","volume":"127","author":"K. P. MacDonald","year":"2017","journal-title":"J Clin Invest"},{"issue":"3","key":"ref11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"M. H. Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"ref12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1056\/NEJM199907013410103","article-title":"Late Effects Working Committee of the International Bone Marrow Transplant Registry. Long-term survival and late deaths after allogeneic bone marrow transplantation","volume":"341","author":"G. Soci\u00e9","year":"1999","journal-title":"N Engl J Med"},{"issue":"4","key":"ref13","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/ajh.23656","article-title":"Factors associated with bronchiolitis obliterans syndrome and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation","volume":"89","author":"L. Gazourian","year":"2014","journal-title":"Am J Hematol"},{"issue":"4","key":"ref14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1200\/JCO.21.02293","article-title":"Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies","volume":"40","author":"L. Luznik","year":"2022","journal-title":"J Clin Oncol"},{"issue":"5","key":"ref15","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.bbmt.2005.12.034","article-title":"Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation","volume":"12","author":"A. Bacigalupo","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"ref16","doi-asserted-by":"publisher","first-page":"587.e1","DOI":"10.1016\/j.jtct.2022.06.006","article-title":"Impact of the Addition of Antithymocyte Globulin to Post-Transplantation Cyclophosphamide in Haploidentical Transplantation with Peripheral Blood Compared to Post-Transplantation Cyclophosphamide Alone in Acute Myelogenous Leukemia: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","volume":"28","author":"G. Battipaglia","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"4","key":"ref17","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.bbmt.2015.10.009","article-title":"Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation","volume":"22","author":"K. M. Williams","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"23","key":"ref18","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1182\/blood.2022016926","article-title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","volume":"140","author":"N. Vallet","year":"2022","journal-title":"Blood"},{"issue":"3","key":"ref19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1056\/NEJMoa2033122","article-title":"Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease","volume":"385","author":"R. Zeiser","year":"2021","journal-title":"N Engl J Med."}],"container-title":["Clinical Hematology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/chi.scholasticahq.com\/article\/124551-pulmonary-gvhd-is-it-time-to-change-the-nih-diagnostic-criteria","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:43:11Z","timestamp":1784734991000},"score":1,"resource":{"primary":{"URL":"https:\/\/chi.scholasticahq.com\/article\/124551-pulmonary-gvhd-is-it-time-to-change-the-nih-diagnostic-criteria"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,19]]},"references-count":19,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.46989\/001c.124551","relation":{},"ISSN":["2590-0048"],"issn-type":[{"value":"2590-0048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,19]]}}}